NR1H4 and cholestasis: Part of the beneficial effects of FXR agonists in cholestasis may be attributed to FXR-dependent induction of FGF19, and selective activation of FXR in the intestine even suggests that induction of ileal FGF19 may sufficiently treat cholestasis37.